NZ222083A - Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose - Google Patents

Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose

Info

Publication number
NZ222083A
NZ222083A NZ222083A NZ22208387A NZ222083A NZ 222083 A NZ222083 A NZ 222083A NZ 222083 A NZ222083 A NZ 222083A NZ 22208387 A NZ22208387 A NZ 22208387A NZ 222083 A NZ222083 A NZ 222083A
Authority
NZ
New Zealand
Prior art keywords
composition according
hydroxypropyl methylcellulose
microcrystalline cellulose
acetylsalicylic acid
asa
Prior art date
Application number
NZ222083A
Other languages
English (en)
Inventor
Henry C Gan
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ222083A publication Critical patent/NZ222083A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ222083A 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose NZ222083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NZ222083A true NZ222083A (en) 1991-05-28

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ222083A NZ222083A (en) 1986-10-09 1987-10-07 Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose

Country Status (24)

Country Link
JP (1) JPS63101334A (fr)
KR (1) KR880004801A (fr)
AU (1) AU7942087A (fr)
BE (1) BE1000732A5 (fr)
CA (1) CA1332809C (fr)
CH (1) CH675831A5 (fr)
DE (1) DE3733540A1 (fr)
DK (1) DK527487A (fr)
ES (1) ES2014518A6 (fr)
FI (1) FI874414A (fr)
FR (1) FR2604902B1 (fr)
GB (2) GB8624213D0 (fr)
GR (1) GR871550B (fr)
HU (1) HU201875B (fr)
IL (1) IL84104A0 (fr)
IT (1) IT1221493B (fr)
LU (1) LU87009A1 (fr)
NL (1) NL8702294A (fr)
NO (1) NO874200L (fr)
NZ (1) NZ222083A (fr)
PH (1) PH24227A (fr)
PT (1) PT85880B (fr)
SE (1) SE8703889L (fr)
ZA (1) ZA877617B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EA005291B1 (ru) 1999-03-31 2004-12-30 Янссен Фармацевтика Н.В. Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
CN101039661A (zh) * 2004-09-09 2007-09-19 普西考法玛公司 用于肼苯哒嗪缓释的药物组合物及其作为癌症治疗载体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
SE8703889L (sv) 1988-04-10
IT1221493B (it) 1990-07-06
GB8624213D0 (en) 1986-11-12
GB2195893B (en) 1991-05-08
DK527487A (da) 1988-04-10
CH675831A5 (fr) 1990-11-15
CA1332809C (fr) 1994-11-01
HUT52958A (en) 1990-09-28
SE8703889D0 (sv) 1987-10-08
GR871550B (en) 1988-02-15
PT85880A (en) 1987-11-01
BE1000732A5 (fr) 1989-03-21
ES2014518A6 (es) 1990-07-16
DE3733540A1 (de) 1988-04-14
DK527487D0 (da) 1987-10-08
KR880004801A (ko) 1988-06-27
JPS63101334A (ja) 1988-05-06
NO874200D0 (no) 1987-10-07
PT85880B (pt) 1990-07-31
NO874200L (no) 1988-04-11
NL8702294A (nl) 1988-05-02
FI874414A (fi) 1988-04-10
ZA877617B (en) 1989-05-30
HU201875B (en) 1991-01-28
IT8748469A0 (it) 1987-10-08
GB2195893A (en) 1988-04-20
GB8723515D0 (en) 1987-11-11
FR2604902B1 (fr) 1991-04-26
FI874414A0 (fi) 1987-10-07
FR2604902A1 (fr) 1988-04-15
LU87009A1 (fr) 1988-05-03
IL84104A0 (en) 1988-03-31
AU7942087A (en) 1988-04-14
PH24227A (en) 1990-05-04

Similar Documents

Publication Publication Date Title
EP1058538B2 (fr) Comprime a desintegration rapide
JP3037757B2 (ja) パロキセチン錠およびその製法
PT1351668E (pt) Formas de dosagem farmacêutica de libertação sustida com perfis de dissolução dependentes de ph minimizado
AU2002249881A1 (en) Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles
JPH07558B2 (ja) モピダモール製剤
JPH03200724A (ja) 二重作用錠剤
AU721851B2 (en) Swallow tablet comprising paracetamol
CA2182004C (fr) Comprimes enrobes de paracetamol et de domperidone
WO2000015196A1 (fr) Composition pharmaceutique comprenant une entacapone ou nitecapone, de meme qu'un derive de cellulose reticule
HU219246B (en) Solid pharmaceutical compositions containing (s)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients and pharmaceutical forms prepared by using these compositions
NZ222083A (en) Sustained release pharmaceutical compositions containing microcrystalline cellulose and hydroxypropyl methylcellulose
EP1763338B1 (fr) Formulation orale de tedisamil à libération prolongée avec des propriétés de rétention gastrique
EP1392271B1 (fr) Comprime a avaler renfermant du paracetamol
ES2614757T3 (es) Nueva composición de alfentanilo para el tratamiento del dolor agudo
AU2002317772A1 (en) Swallow tablet comprising paracetamol
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JP3836893B2 (ja) ポリカルボフィルカルシウム含有製剤
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
TW200304807A (en) Sleeping medicine formed by coating solid
JP4999297B2 (ja) 高含量塩酸テルビナフィン小型錠剤
NZ207768A (en) Sustained release tablets comprising dipyridamole
WO2005065662A1 (fr) Formulations solides d'administration de galantamine
Naik et al. Development of single unit floating-pulsatile site specific drug delivery system for chronotherapeutic release of aceclofenac
WO1998042310A2 (fr) Composition therapeutique
JP2023163350A (ja) チュアブル錠又は口腔内崩壊錠